These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19623170)

  • 1. Clusterin in stool: a new biomarker for colon cancer screening?
    Pucci S; Bonanno E; Sesti F; Mazzarelli P; Mauriello A; Ricci F; Zoccai GB; Rulli F; Galatà G; Spagnoli LG
    Am J Gastroenterol; 2009 Nov; 104(11):2807-15. PubMed ID: 19623170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLU and colon cancer. The dual face of CLU: from normal to malignant phenotype.
    Mazzarelli P; Pucci S; Spagnoli LG
    Adv Cancer Res; 2009; 105():45-61. PubMed ID: 19879422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of faecal tests for the detection of colon cancer: a new strategy for an appropriate selection of referrals to colonoscopy? A prospective multicentre Italian study.
    Parente F; Marino B; Ilardo A; Fracasso P; Zullo A; Hassan C; Moretti R; Cremaschini M; Ardizzoia A; Saracino I; Perna F; Vaira D
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1145-52. PubMed ID: 22735608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting soluble clusterin in in-vitro and in-vivo models of prostate cancer.
    Girard FP; Byrne J; Downes M; Fanning D; Desgrandchamps F; Fitzpatrick JM; Watson RW
    Neoplasma; 2010; 57(5):488-93. PubMed ID: 20568904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colon Cancer Screening - Is It Time Yet?
    Bhurgri H; Samiullah S
    J Coll Physicians Surg Pak; 2017 Jun; 27(6):327-328. PubMed ID: 28689518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood Markers for Colorectal Cancer-Validation in a Cohort of Subjects With Positive Fecal Immunochemical Test Result.
    Rodia MT; Solmi R; Pasini F; Nardi E; Mattei G; Ugolini G; Ricciardiello L; Strippoli P; Miglio R; Lauriola M
    Clin Colorectal Cancer; 2018 Jun; 17(2):e217-e228. PubMed ID: 29352642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test.
    Dollinger MM; Behl S; Fleig WE
    Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
    Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
    J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma.
    Zheng W; Yao M; Sai W; Qian Q; Pan L; Qiu L; Huang J; Wu W; Yao D
    Tumour Biol; 2016 Jan; 37(1):999-1008. PubMed ID: 26264614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
    Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
    Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
    Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer.
    Rezasoltani S; Sharafkhah M; Asadzadeh Aghdaei H; Nazemalhosseini Mojarad E; Dabiri H; Akhavan Sepahi A; Modarressi MH; Feizabadi MM; Zali MR
    J Microbiol Methods; 2018 Dec; 155():82-88. PubMed ID: 30439465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients.
    Haug U; Rothenbacher D; Wente MN; Seiler CM; Stegmaier C; Brenner H
    Br J Cancer; 2007 May; 96(9):1329-34. PubMed ID: 17406361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel multiplex stool-based assay for the detection of early-stage colon cancer in a Chinese population.
    Jiang HH; Xing SW; Tang X; Chen Y; Lin K; He LW; Lin MB; Tang EJ
    World J Gastroenterol; 2022 Jun; 28(24):2705-2732. PubMed ID: 35979157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.
    Slaby O
    Adv Exp Med Biol; 2016; 937():153-70. PubMed ID: 27573899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
    Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
    Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
    Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.